Jericho Wd

PFAS monitoring results for a public water system in New York

NY2902831UCMR 5EPA monitoring data
<MRLHighest PFOA result, ppt
<MRLHighest PFOS result, ppt
0Highest Hazard Index
975Results
PWSID
NY2902831
State
New York
System type
community water system (CWS)
Population served
58,000
City
Syosset
Counties
Nassau County
Primary source water
groundwater
UCMR 5 sampling
2023-04-25 to 2025-11-12 · 20 entry point(s) · water types: GW
Service-area boundary
authoritative

Other PFAS detected highest single result
Other PFAS detected worst entry-point average

These are monitoring results collected under EPA's Fifth Unregulated Contaminant Monitoring Rule (UCMR 5) at entry points, where treated water enters the distribution system; they are not tap-water samples. They are not compliance determinations: compliance with EPA's 2024 PFAS limits is judged on running annual averages of compliance monitoring, required from 2029, so a single UCMR 5 result at or above a limit is not a violation. “< MRL” means the compound was not quantified at EPA's minimum reporting level; it does not mean zero.

Compared with EPA's 2024 values

Highest single resultWorst entry-point average*Limit
PFOA (ppt)<MRL04
PFOS (ppt)<MRL04
Hazard Index001.0†

“<MRL” = every result for the compound was below its reporting limit. * Mean of all samples at each entry point with non-detects = 0 (EPA compliance convention; the Hazard Index also uses non-detects = 0); a screening comparison, not a formal running annual average. † Rescission proposed May 2026. PFOA/PFOS MCL 4 ppt (2024 NPDWR, in effect). PFHxS, PFNA, HFPO-DA (10 ppt each) and the Hazard Index (1.0) are 2024 NPDWR values; EPA proposed rescinding them on 18 May 2026 (comment period closed 20 Jul 2026).

Compared with New York standards

Highest single resultWorst entry-point average*New York
PFOA (ppt)0010
PFOS (ppt)0010

Sum standards add the listed compounds within each sample (non-detects = 0). State compliance is normally judged on averages over time; these are screening comparisons.

Sampling history

Sampled 2023-04-25 to 2025-11-12 · 20 entry point(s) · water types: GW · 49 sampling visits. PFAS in ppt (ng/L).

DateEntry pointEventPFOAPFOSHIOther detections
2023-04-25Well 27 Treatment (GW)SE1n/an/an/anone
2023-04-25Well 28 (GW)SE1n/an/an/anone
2023-04-25Well 31 Treatment (GW)SE1n/an/an/anone
2023-04-25Well 9 Treatment (GW)SE1n/an/an/anone
2023-04-25Wells 29 & 30 Treatment (GW)SE1n/an/an/anone
2023-04-28Well 11 Treatment (GW)SE1n/an/an/anone
2023-04-28Well 12 Treatment (GW)SE1n/an/an/anone
2023-04-28Well 13 Treatment (GW)SE1n/an/an/anone
2023-04-28Well 14 Treatment (GW)SE1n/an/an/anone
2023-04-28Well 17 Treatment (GW)SE1n/an/an/anone
2023-04-28Well 18 Treatment (GW)SE1n/an/an/anone
2023-04-28Well 19 Treatment (GW)SE1n/an/an/anone
2023-04-28Well 23 Treatment (GW)SE1n/an/an/anone
2023-04-28Well 3 Treatment (GW)SE1<4<406:2 FTS 9.9
2023-04-28Well 4 Treatment (GW)SE1n/an/an/anone
2023-07-10Well 16 Treatment (GW)SE1<4<40none
2023-07-10Well 6 Treatment (GW)SE1<4<40none
2023-07-18Well 13 Treatment (GW)SE1<4<40none
2023-09-01Well 14 Treatment (GW)SE1<4<40PFHxA 3.4, PFPeA 5.3
2023-09-01Well 17 Treatment (GW)SE1<4<40PFBA 7.6
2023-09-01Well 18 Treatment (GW)SE1<4<40PFBA 56, PFHpA 3.8, PFHxA 14, PFPeA 31
2023-09-01Well 4 Treatment (GW)SE1<4<40PFBA 17, PFPeA 3.9
2023-10-16Well 11 Treatment (GW)SE2<4<40none
2023-10-16Well 12 Treatment (GW)SE2<4<40none
2023-10-16Well 13 Treatment (GW)SE2<4<40none
2023-10-16Well 14 Treatment (GW)SE2<4<40PFBA 8.8
2023-10-16Well 17 Treatment (GW)SE2<4<40PFBA 5.9
2023-10-16Well 18 Treatment (GW)SE2<4<40PFBA 56, PFHpA 4.6, PFHxA 18, PFPeA 37
2023-10-16Well 19 Treatment (GW)SE2<4<40PFHxA 3.9, PFPeA 5.7
2023-10-16Well 23 Treatment (GW)SE2<4<40PFBA 67, PFHxA 6.3, PFPeA 22
2023-10-16Well 3 Treatment (GW)SE2<4<40none
2023-10-16Well 9 Treatment (GW)SE2<4<40PFBA 5.9
2023-10-18Well 28 (GW)SE2<4<40none
2023-10-18Well 31 Treatment (GW)SE2<4<40none
2023-10-18Well 4 Treatment (GW)SE2<4<40PFBA 20, PFPeA 4.4
2023-10-18Wells 29 & 30 Treatment (GW)SE2<4<40PFBA 6.4, PFHxA 4.5, PFPeA 5.4
2023-10-30Well 27 Treatment (GW)SE2<4<40none
2023-12-04Well 16 Treatment (GW)SE2<4<40none
2023-12-04Well 6 Treatment (GW)SE2<4<40none
2025-05-29Well 25 Treatment (GW)SE1n/an/an/anone
2025-05-29Well 26 Treatment (GW)SE1n/an/an/anone
2025-05-29Wells 20 & 21 Treatment (GW)SE1n/an/an/anone
2025-06-24Well 25 Treatment (GW)SE1<4<40none
2025-06-24Well 26 Treatment (GW)SE1<4<40none
2025-06-24Wells 20 & 21 Treatment (GW)SE1<4<40none
2025-07-02Well 25 Treatment (GW)SE1n/an/an/anone
2025-11-12Well 25 Treatment (GW)SE2<4<40none
2025-11-12Well 26 Treatment (GW)SE2<4<40PFBA 26
2025-11-12Wells 20 & 21 Treatment (GW)SE2<4<40none

“<4” = not detected at the reporting limit shown; “n/a” = not analyzed in that sample. Highlighted = at or above the 4 ppt MCL. HI computed per sample with non-detects as 0. Other detections lists every other quantified compound (lithium in µg/L).

All results by entry point

975 results. Each column is one sampling visit (date and UCMR 5 sample event). A number is a measured concentration; “< 4” = below the minimum reporting level shown; “–” = not analyzed in that visit. PFAS in ppt (ng/L); lithium in µg/L.

Well 11 Treatment facility 05201 · sample point EPW11 · groundwater

CompoundMRL2023-04-28
SE1
2023-10-16
SE2
11Cl-PF3OUdS5 ppt–< 5
4:2 FTS3 ppt–< 3
6:2 FTS5 ppt–< 5
8:2 FTS5 ppt–< 5
9Cl-PF3ONS2 ppt–< 2
ADONA3 ppt–< 3
HFPO-DA5 ppt–< 5
NEtFOSAA5 ppt< 5< 5
NFDHA20 ppt–< 20
NMeFOSAA6 ppt< 6< 6
PFBA5 ppt–< 5
PFBS3 ppt–< 3
PFDA3 ppt–< 3
PFDoA3 ppt–< 3
PFEESA3 ppt–< 3
PFHpA3 ppt–< 3
PFHpS3 ppt–< 3
PFHxA3 ppt–< 3
PFHxS3 ppt–< 3
PFMBA3 ppt–< 3
PFMPA4 ppt–< 4
PFNA4 ppt–< 4
PFOA4 ppt–< 4
PFOS4 ppt–< 4
PFPeA3 ppt–< 3
PFPeS4 ppt–< 4
PFTA8 ppt< 8< 8
PFTrDA7 ppt< 7< 7
PFUnA2 ppt–< 2
lithium9 µg/L< 9< 9

Well 12 Treatment facility 06092 · sample point EPW12 · groundwater

CompoundMRL2023-04-28
SE1
2023-10-16
SE2
11Cl-PF3OUdS5 ppt–< 5
4:2 FTS3 ppt–< 3
6:2 FTS5 ppt–< 5
8:2 FTS5 ppt–< 5
9Cl-PF3ONS2 ppt–< 2
ADONA3 ppt–< 3
HFPO-DA5 ppt–< 5
NEtFOSAA5 ppt< 5< 5
NFDHA20 ppt–< 20
NMeFOSAA6 ppt< 6< 6
PFBA5 ppt–< 5
PFBS3 ppt–< 3
PFDA3 ppt–< 3
PFDoA3 ppt–< 3
PFEESA3 ppt–< 3
PFHpA3 ppt–< 3
PFHpS3 ppt–< 3
PFHxA3 ppt–< 3
PFHxS3 ppt–< 3
PFMBA3 ppt–< 3
PFMPA4 ppt–< 4
PFNA4 ppt–< 4
PFOA4 ppt–< 4
PFOS4 ppt–< 4
PFPeA3 ppt–< 3
PFPeS4 ppt–< 4
PFTA8 ppt< 8< 8
PFTrDA7 ppt< 7< 7
PFUnA2 ppt–< 2
lithium9 µg/L< 9< 9

Well 13 Treatment facility 06093 · sample point EPW13 · groundwater

CompoundMRL2023-04-28
SE1
2023-07-18
SE1
2023-10-16
SE2
11Cl-PF3OUdS5 ppt–< 5< 5
4:2 FTS3 ppt–< 3< 3
6:2 FTS5 ppt–< 5< 5
8:2 FTS5 ppt–< 5< 5
9Cl-PF3ONS2 ppt–< 2< 2
ADONA3 ppt–< 3< 3
HFPO-DA5 ppt–< 5< 5
NEtFOSAA5 ppt< 5–< 5
NFDHA20 ppt–< 20< 20
NMeFOSAA6 ppt< 6–< 6
PFBA5 ppt–< 5< 5
PFBS3 ppt–< 3< 3
PFDA3 ppt–< 3< 3
PFDoA3 ppt–< 3< 3
PFEESA3 ppt–< 3< 3
PFHpA3 ppt–< 3< 3
PFHpS3 ppt–< 3< 3
PFHxA3 ppt–< 3< 3
PFHxS3 ppt–< 3< 3
PFMBA3 ppt–< 3< 3
PFMPA4 ppt–< 4< 4
PFNA4 ppt–< 4< 4
PFOA4 ppt–< 4< 4
PFOS4 ppt–< 4< 4
PFPeA3 ppt–< 3< 3
PFPeS4 ppt–< 4< 4
PFTA8 ppt< 8–< 8
PFTrDA7 ppt< 7–< 7
PFUnA2 ppt–< 2< 2
lithium9 µg/L< 9–< 9

Well 14 Treatment facility 06651 · sample point EPW14 · groundwater

CompoundMRL2023-04-28
SE1
2023-09-01
SE1
2023-10-16
SE2
PFBA5 ppt–< 58.8
PFHxA3 ppt–3.4< 3
PFPeA3 ppt–5.3< 3
11Cl-PF3OUdS5 ppt–< 5< 5
4:2 FTS3 ppt–< 3< 3
6:2 FTS5 ppt–< 5< 5
8:2 FTS5 ppt–< 5< 5
9Cl-PF3ONS2 ppt–< 2< 2
ADONA3 ppt–< 3< 3
HFPO-DA5 ppt–< 5< 5
NEtFOSAA5 ppt< 5–< 5
NFDHA20 ppt–< 20< 20
NMeFOSAA6 ppt< 6–< 6
PFBS3 ppt–< 3< 3
PFDA3 ppt–< 3< 3
PFDoA3 ppt–< 3< 3
PFEESA3 ppt–< 3< 3
PFHpA3 ppt–< 3< 3
PFHpS3 ppt–< 3< 3
PFHxS3 ppt–< 3< 3
PFMBA3 ppt–< 3< 3
PFMPA4 ppt–< 4< 4
PFNA4 ppt–< 4< 4
PFOA4 ppt–< 4< 4
PFOS4 ppt–< 4< 4
PFPeS4 ppt–< 4< 4
PFTA8 ppt< 8–< 8
PFTrDA7 ppt< 7–< 7
PFUnA2 ppt–< 2< 2
lithium9 µg/L< 9–< 9

Well 16 Treatment facility 07446 · sample point EPW16 · groundwater

CompoundMRL2023-07-10
SE1
2023-12-04
SE2
11Cl-PF3OUdS5 ppt< 5< 5
4:2 FTS3 ppt< 3< 3
6:2 FTS5 ppt< 5< 5
8:2 FTS5 ppt< 5< 5
9Cl-PF3ONS2 ppt< 2< 2
ADONA3 ppt< 3< 3
HFPO-DA5 ppt< 5< 5
NEtFOSAA5 ppt< 5< 5
NFDHA20 ppt< 20< 20
NMeFOSAA6 ppt< 6< 6
PFBA5 ppt< 5< 5
PFBS3 ppt< 3< 3
PFDA3 ppt< 3< 3
PFDoA3 ppt< 3< 3
PFEESA3 ppt< 3< 3
PFHpA3 ppt< 3< 3
PFHpS3 ppt< 3< 3
PFHxA3 ppt< 3< 3
PFHxS3 ppt< 3< 3
PFMBA3 ppt< 3< 3
PFMPA4 ppt< 4< 4
PFNA4 ppt< 4< 4
PFOA4 ppt< 4< 4
PFOS4 ppt< 4< 4
PFPeA3 ppt< 3< 3
PFPeS4 ppt< 4< 4
PFTA8 ppt< 8< 8
PFTrDA7 ppt< 7< 7
PFUnA2 ppt< 2< 2
lithium9 µg/L< 9< 9

Well 17 Treatment facility 07593 · sample point EPW17 · groundwater

CompoundMRL2023-04-28
SE1
2023-09-01
SE1
2023-10-16
SE2
PFBA5 ppt–7.65.9
11Cl-PF3OUdS5 ppt–< 5< 5
4:2 FTS3 ppt–< 3< 3
6:2 FTS5 ppt–< 5< 5
8:2 FTS5 ppt–< 5< 5
9Cl-PF3ONS2 ppt–< 2< 2
ADONA3 ppt–< 3< 3
HFPO-DA5 ppt–< 5< 5
NEtFOSAA5 ppt< 5–< 5
NFDHA20 ppt–< 20< 20
NMeFOSAA6 ppt< 6–< 6
PFBS3 ppt–< 3< 3
PFDA3 ppt–< 3< 3
PFDoA3 ppt–< 3< 3
PFEESA3 ppt–< 3< 3
PFHpA3 ppt–< 3< 3
PFHpS3 ppt–< 3< 3
PFHxA3 ppt–< 3< 3
PFHxS3 ppt–< 3< 3
PFMBA3 ppt–< 3< 3
PFMPA4 ppt–< 4< 4
PFNA4 ppt–< 4< 4
PFOA4 ppt–< 4< 4
PFOS4 ppt–< 4< 4
PFPeA3 ppt–< 3< 3
PFPeS4 ppt–< 4< 4
PFTA8 ppt< 8–< 8
PFTrDA7 ppt< 7–< 7
PFUnA2 ppt–< 2< 2
lithium9 µg/L< 9–< 9

Well 18 Treatment facility 07772 · sample point EPW18 · groundwater

CompoundMRL2023-04-28
SE1
2023-09-01
SE1
2023-10-16
SE2
PFBA5 ppt–5656
PFHpA3 ppt–3.84.6
PFHxA3 ppt–1418
PFPeA3 ppt–3137
11Cl-PF3OUdS5 ppt–< 5< 5
4:2 FTS3 ppt–< 3< 3
6:2 FTS5 ppt–< 5< 5
8:2 FTS5 ppt–< 5< 5
9Cl-PF3ONS2 ppt–< 2< 2
ADONA3 ppt–< 3< 3
HFPO-DA5 ppt–< 5< 5
NEtFOSAA5 ppt< 5–< 5
NFDHA20 ppt–< 20< 20
NMeFOSAA6 ppt< 6–< 6
PFBS3 ppt–< 3< 3
PFDA3 ppt–< 3< 3
PFDoA3 ppt–< 3< 3
PFEESA3 ppt–< 3< 3
PFHpS3 ppt–< 3< 3
PFHxS3 ppt–< 3< 3
PFMBA3 ppt–< 3< 3
PFMPA4 ppt–< 4< 4
PFNA4 ppt–< 4< 4
PFOA4 ppt–< 4< 4
PFOS4 ppt–< 4< 4
PFPeS4 ppt–< 4< 4
PFTA8 ppt< 8–< 8
PFTrDA7 ppt< 7–< 7
PFUnA2 ppt–< 2< 2
lithium9 µg/L< 9–< 9

Well 19 Treatment facility 07773 · sample point EPW19 · groundwater

CompoundMRL2023-04-28
SE1
2023-10-16
SE2
PFHxA3 ppt–3.9
PFPeA3 ppt–5.7
11Cl-PF3OUdS5 ppt–< 5
4:2 FTS3 ppt–< 3
6:2 FTS5 ppt–< 5
8:2 FTS5 ppt–< 5
9Cl-PF3ONS2 ppt–< 2
ADONA3 ppt–< 3
HFPO-DA5 ppt–< 5
NEtFOSAA5 ppt< 5< 5
NFDHA20 ppt–< 20
NMeFOSAA6 ppt< 6< 6
PFBA5 ppt–< 5
PFBS3 ppt–< 3
PFDA3 ppt–< 3
PFDoA3 ppt–< 3
PFEESA3 ppt–< 3
PFHpA3 ppt–< 3
PFHpS3 ppt–< 3
PFHxS3 ppt–< 3
PFMBA3 ppt–< 3
PFMPA4 ppt–< 4
PFNA4 ppt–< 4
PFOA4 ppt–< 4
PFOS4 ppt–< 4
PFPeS4 ppt–< 4
PFTA8 ppt< 8< 8
PFTrDA7 ppt< 7< 7
PFUnA2 ppt–< 2
lithium9 µg/L< 9< 9

Well 23 Treatment facility 08043 · sample point EPW23 · groundwater

CompoundMRL2023-04-28
SE1
2023-10-16
SE2
PFBA5 ppt–67
PFHxA3 ppt–6.3
PFPeA3 ppt–22
11Cl-PF3OUdS5 ppt–< 5
4:2 FTS3 ppt–< 3
6:2 FTS5 ppt–< 5
8:2 FTS5 ppt–< 5
9Cl-PF3ONS2 ppt–< 2
ADONA3 ppt–< 3
HFPO-DA5 ppt–< 5
NEtFOSAA5 ppt< 5< 5
NFDHA20 ppt–< 20
NMeFOSAA6 ppt< 6< 6
PFBS3 ppt–< 3
PFDA3 ppt–< 3
PFDoA3 ppt–< 3
PFEESA3 ppt–< 3
PFHpA3 ppt–< 3
PFHpS3 ppt–< 3
PFHxS3 ppt–< 3
PFMBA3 ppt–< 3
PFMPA4 ppt–< 4
PFNA4 ppt–< 4
PFOA4 ppt–< 4
PFOS4 ppt–< 4
PFPeS4 ppt–< 4
PFTA8 ppt< 8< 8
PFTrDA7 ppt< 7< 7
PFUnA2 ppt–< 2
lithium9 µg/L< 9< 9

Well 25 Treatment facility 08355 · sample point EPW25 · groundwater

CompoundMRL2025-05-29
SE1
2025-06-24
SE1
2025-07-02
SE1
2025-11-12
SE2
11Cl-PF3OUdS5 ppt–< 5–< 5
4:2 FTS3 ppt–< 3–< 3
6:2 FTS5 ppt–< 5–< 5
8:2 FTS5 ppt–< 5–< 5
9Cl-PF3ONS2 ppt–< 2–< 2
ADONA3 ppt–< 3–< 3
HFPO-DA5 ppt–< 5–< 5
NEtFOSAA5 ppt––< 5< 5
NFDHA20 ppt–< 20–< 20
NMeFOSAA6 ppt––< 6< 6
PFBA5 ppt–< 5–< 5
PFBS3 ppt–< 3–< 3
PFDA3 ppt–< 3–< 3
PFDoA3 ppt–< 3–< 3
PFEESA3 ppt–< 3–< 3
PFHpA3 ppt–< 3–< 3
PFHpS3 ppt–< 3–< 3
PFHxA3 ppt–< 3–< 3
PFHxS3 ppt–< 3–< 3
PFMBA3 ppt–< 3–< 3
PFMPA4 ppt–< 4–< 4
PFNA4 ppt–< 4–< 4
PFOA4 ppt–< 4–< 4
PFOS4 ppt–< 4–< 4
PFPeA3 ppt–< 3–< 3
PFPeS4 ppt–< 4–< 4
PFTA8 ppt––< 8< 8
PFTrDA7 ppt––< 7< 7
PFUnA2 ppt–< 2–< 2
lithium9 µg/L< 9––< 9

Well 26 Treatment facility 13119 · sample point EPW26 · groundwater

CompoundMRL2025-05-29
SE1
2025-06-24
SE1
2025-11-12
SE2
PFBA5 ppt–< 526
11Cl-PF3OUdS5 ppt–< 5< 5
4:2 FTS3 ppt–< 3< 3
6:2 FTS5 ppt–< 5< 5
8:2 FTS5 ppt–< 5< 5
9Cl-PF3ONS2 ppt–< 2< 2
ADONA3 ppt–< 3< 3
HFPO-DA5 ppt–< 5< 5
NEtFOSAA5 ppt–< 5< 5
NFDHA20 ppt–< 20< 20
NMeFOSAA6 ppt–< 6< 6
PFBS3 ppt–< 3< 3
PFDA3 ppt–< 3< 3
PFDoA3 ppt–< 3< 3
PFEESA3 ppt–< 3< 3
PFHpA3 ppt–< 3< 3
PFHpS3 ppt–< 3< 3
PFHxA3 ppt–< 3< 3
PFHxS3 ppt–< 3< 3
PFMBA3 ppt–< 3< 3
PFMPA4 ppt–< 4< 4
PFNA4 ppt–< 4< 4
PFOA4 ppt–< 4< 4
PFOS4 ppt–< 4< 4
PFPeA3 ppt–< 3< 3
PFPeS4 ppt–< 4< 4
PFTA8 ppt–< 8< 8
PFTrDA7 ppt–< 7< 7
PFUnA2 ppt–< 2< 2
lithium9 µg/L< 9–< 9

Well 27 Treatment facility 08713 · sample point EPW27 · groundwater

CompoundMRL2023-04-25
SE1
2023-10-30
SE2
11Cl-PF3OUdS5 ppt–< 5
4:2 FTS3 ppt–< 3
6:2 FTS5 ppt–< 5
8:2 FTS5 ppt–< 5
9Cl-PF3ONS2 ppt–< 2
ADONA3 ppt–< 3
HFPO-DA5 ppt–< 5
NEtFOSAA5 ppt< 5< 5
NFDHA20 ppt–< 20
NMeFOSAA6 ppt< 6< 6
PFBA5 ppt–< 5
PFBS3 ppt–< 3
PFDA3 ppt–< 3
PFDoA3 ppt–< 3
PFEESA3 ppt–< 3
PFHpA3 ppt–< 3
PFHpS3 ppt–< 3
PFHxA3 ppt–< 3
PFHxS3 ppt–< 3
PFMBA3 ppt–< 3
PFMPA4 ppt–< 4
PFNA4 ppt–< 4
PFOA4 ppt–< 4
PFOS4 ppt–< 4
PFPeA3 ppt–< 3
PFPeS4 ppt–< 4
PFTA8 ppt< 8< 8
PFTrDA7 ppt< 7< 7
PFUnA2 ppt–< 2
lithium9 µg/L< 9< 9

Well 28 facility 14003 · sample point EPW28 · groundwater

CompoundMRL2023-04-25
SE1
2023-10-18
SE2
11Cl-PF3OUdS5 ppt–< 5
4:2 FTS3 ppt–< 3
6:2 FTS5 ppt–< 5
8:2 FTS5 ppt–< 5
9Cl-PF3ONS2 ppt–< 2
ADONA3 ppt–< 3
HFPO-DA5 ppt–< 5
NEtFOSAA5 ppt< 5< 5
NFDHA20 ppt–< 20
NMeFOSAA6 ppt< 6< 6
PFBA5 ppt–< 5
PFBS3 ppt–< 3
PFDA3 ppt–< 3
PFDoA3 ppt–< 3
PFEESA3 ppt–< 3
PFHpA3 ppt–< 3
PFHpS3 ppt–< 3
PFHxA3 ppt–< 3
PFHxS3 ppt–< 3
PFMBA3 ppt–< 3
PFMPA4 ppt–< 4
PFNA4 ppt–< 4
PFOA4 ppt–< 4
PFOS4 ppt–< 4
PFPeA3 ppt–< 3
PFPeS4 ppt–< 4
PFTA8 ppt< 8< 8
PFTrDA7 ppt< 7< 7
PFUnA2 ppt–< 2
lithium9 µg/L< 9< 9

Well 3 Treatment facility 00198 · sample point EPW3 · groundwater

CompoundMRL2023-04-28
SE1
2023-10-16
SE2
6:2 FTS5 ppt9.9< 5
11Cl-PF3OUdS5 ppt< 5< 5
4:2 FTS3 ppt< 3< 3
8:2 FTS5 ppt< 5< 5
9Cl-PF3ONS2 ppt< 2< 2
ADONA3 ppt< 3< 3
HFPO-DA5 ppt< 5< 5
NEtFOSAA5 ppt< 5< 5
NFDHA20 ppt< 20< 20
NMeFOSAA6 ppt< 6< 6
PFBA5 ppt< 5< 5
PFBS3 ppt< 3< 3
PFDA3 ppt< 3< 3
PFDoA3 ppt< 3< 3
PFEESA3 ppt< 3< 3
PFHpA3 ppt< 3< 3
PFHpS3 ppt< 3< 3
PFHxA3 ppt< 3< 3
PFHxS3 ppt< 3< 3
PFMBA3 ppt< 3< 3
PFMPA4 ppt< 4< 4
PFNA4 ppt< 4< 4
PFOA4 ppt< 4< 4
PFOS4 ppt< 4< 4
PFPeA3 ppt< 3< 3
PFPeS4 ppt< 4< 4
PFTA8 ppt< 8< 8
PFTrDA7 ppt< 7< 7
PFUnA2 ppt< 2< 2
lithium9 µg/L< 9< 9

Well 31 Treatment facility 13268 · sample point EPW31 · groundwater

CompoundMRL2023-04-25
SE1
2023-10-18
SE2
11Cl-PF3OUdS5 ppt–< 5
4:2 FTS3 ppt–< 3
6:2 FTS5 ppt–< 5
8:2 FTS5 ppt–< 5
9Cl-PF3ONS2 ppt–< 2
ADONA3 ppt–< 3
HFPO-DA5 ppt–< 5
NEtFOSAA5 ppt< 5< 5
NFDHA20 ppt–< 20
NMeFOSAA6 ppt< 6< 6
PFBA5 ppt–< 5
PFBS3 ppt–< 3
PFDA3 ppt–< 3
PFDoA3 ppt–< 3
PFEESA3 ppt–< 3
PFHpA3 ppt–< 3
PFHpS3 ppt–< 3
PFHxA3 ppt–< 3
PFHxS3 ppt–< 3
PFMBA3 ppt–< 3
PFMPA4 ppt–< 4
PFNA4 ppt–< 4
PFOA4 ppt–< 4
PFOS4 ppt–< 4
PFPeA3 ppt–< 3
PFPeS4 ppt–< 4
PFTA8 ppt< 8< 8
PFTrDA7 ppt< 7< 7
PFUnA2 ppt–< 2
lithium9 µg/L< 9< 9

Well 4 Treatment facility 12734 · sample point EPW4 · groundwater

CompoundMRL2023-04-28
SE1
2023-09-01
SE1
2023-10-18
SE2
PFBA5 ppt–1720
PFPeA3 ppt–3.94.4
11Cl-PF3OUdS5 ppt–< 5< 5
4:2 FTS3 ppt–< 3< 3
6:2 FTS5 ppt–< 5< 5
8:2 FTS5 ppt–< 5< 5
9Cl-PF3ONS2 ppt–< 2< 2
ADONA3 ppt–< 3< 3
HFPO-DA5 ppt–< 5< 5
NEtFOSAA5 ppt< 5–< 5
NFDHA20 ppt–< 20< 20
NMeFOSAA6 ppt< 6–< 6
PFBS3 ppt–< 3< 3
PFDA3 ppt–< 3< 3
PFDoA3 ppt–< 3< 3
PFEESA3 ppt–< 3< 3
PFHpA3 ppt–< 3< 3
PFHpS3 ppt–< 3< 3
PFHxA3 ppt–< 3< 3
PFHxS3 ppt–< 3< 3
PFMBA3 ppt–< 3< 3
PFMPA4 ppt–< 4< 4
PFNA4 ppt–< 4< 4
PFOA4 ppt–< 4< 4
PFOS4 ppt–< 4< 4
PFPeS4 ppt–< 4< 4
PFTA8 ppt< 8–< 8
PFTrDA7 ppt< 7–< 7
PFUnA2 ppt–< 2< 2
lithium9 µg/L< 9–< 9

Well 6 Treatment facility 03474 · sample point EPW6 · groundwater

CompoundMRL2023-07-10
SE1
2023-12-04
SE2
11Cl-PF3OUdS5 ppt< 5< 5
4:2 FTS3 ppt< 3< 3
6:2 FTS5 ppt< 5< 5
8:2 FTS5 ppt< 5< 5
9Cl-PF3ONS2 ppt< 2< 2
ADONA3 ppt< 3< 3
HFPO-DA5 ppt< 5< 5
NEtFOSAA5 ppt< 5< 5
NFDHA20 ppt< 20< 20
NMeFOSAA6 ppt< 6< 6
PFBA5 ppt< 5< 5
PFBS3 ppt< 3< 3
PFDA3 ppt< 3< 3
PFDoA3 ppt< 3< 3
PFEESA3 ppt< 3< 3
PFHpA3 ppt< 3< 3
PFHpS3 ppt< 3< 3
PFHxA3 ppt< 3< 3
PFHxS3 ppt< 3< 3
PFMBA3 ppt< 3< 3
PFMPA4 ppt< 4< 4
PFNA4 ppt< 4< 4
PFOA4 ppt< 4< 4
PFOS4 ppt< 4< 4
PFPeA3 ppt< 3< 3
PFPeS4 ppt< 4< 4
PFTA8 ppt< 8< 8
PFTrDA7 ppt< 7< 7
PFUnA2 ppt< 2< 2
lithium9 µg/L< 9< 9

Well 9 Treatment facility 04245 · sample point EPW9 · groundwater

CompoundMRL2023-04-25
SE1
2023-10-16
SE2
PFBA5 ppt–5.9
11Cl-PF3OUdS5 ppt–< 5
4:2 FTS3 ppt–< 3
6:2 FTS5 ppt–< 5
8:2 FTS5 ppt–< 5
9Cl-PF3ONS2 ppt–< 2
ADONA3 ppt–< 3
HFPO-DA5 ppt–< 5
NEtFOSAA5 ppt< 5< 5
NFDHA20 ppt–< 20
NMeFOSAA6 ppt< 6< 6
PFBS3 ppt–< 3
PFDA3 ppt–< 3
PFDoA3 ppt–< 3
PFEESA3 ppt–< 3
PFHpA3 ppt–< 3
PFHpS3 ppt–< 3
PFHxA3 ppt–< 3
PFHxS3 ppt–< 3
PFMBA3 ppt–< 3
PFMPA4 ppt–< 4
PFNA4 ppt–< 4
PFOA4 ppt–< 4
PFOS4 ppt–< 4
PFPeA3 ppt–< 3
PFPeS4 ppt–< 4
PFTA8 ppt< 8< 8
PFTrDA7 ppt< 7< 7
PFUnA2 ppt–< 2
lithium9 µg/L< 9< 9

Wells 20 & 21 Treatment facility 20021 · sample point E2021 · groundwater

CompoundMRL2025-05-29
SE1
2025-06-24
SE1
2025-11-12
SE2
11Cl-PF3OUdS5 ppt–< 5< 5
4:2 FTS3 ppt–< 3< 3
6:2 FTS5 ppt–< 5< 5
8:2 FTS5 ppt–< 5< 5
9Cl-PF3ONS2 ppt–< 2< 2
ADONA3 ppt–< 3< 3
HFPO-DA5 ppt–< 5< 5
NEtFOSAA5 ppt–< 5< 5
NFDHA20 ppt–< 20< 20
NMeFOSAA6 ppt–< 6< 6
PFBA5 ppt–< 5< 5
PFBS3 ppt–< 3< 3
PFDA3 ppt–< 3< 3
PFDoA3 ppt–< 3< 3
PFEESA3 ppt–< 3< 3
PFHpA3 ppt–< 3< 3
PFHpS3 ppt–< 3< 3
PFHxA3 ppt–< 3< 3
PFHxS3 ppt–< 3< 3
PFMBA3 ppt–< 3< 3
PFMPA4 ppt–< 4< 4
PFNA4 ppt–< 4< 4
PFOA4 ppt–< 4< 4
PFOS4 ppt–< 4< 4
PFPeA3 ppt–< 3< 3
PFPeS4 ppt–< 4< 4
PFTA8 ppt–< 8< 8
PFTrDA7 ppt–< 7< 7
PFUnA2 ppt–< 2< 2
lithium9 µg/L< 9–< 9

Wells 29 & 30 Treatment facility 11107 · sample point E2930 · groundwater

CompoundMRL2023-04-25
SE1
2023-10-18
SE2
PFBA5 ppt–6.4
PFHxA3 ppt–4.5
PFPeA3 ppt–5.4
11Cl-PF3OUdS5 ppt–< 5
4:2 FTS3 ppt–< 3
6:2 FTS5 ppt–< 5
8:2 FTS5 ppt–< 5
9Cl-PF3ONS2 ppt–< 2
ADONA3 ppt–< 3
HFPO-DA5 ppt–< 5
NEtFOSAA5 ppt< 5< 5
NFDHA20 ppt–< 20
NMeFOSAA6 ppt< 6< 6
PFBS3 ppt–< 3
PFDA3 ppt–< 3
PFDoA3 ppt–< 3
PFEESA3 ppt–< 3
PFHpA3 ppt–< 3
PFHpS3 ppt–< 3
PFHxS3 ppt–< 3
PFMBA3 ppt–< 3
PFMPA4 ppt–< 4
PFNA4 ppt–< 4
PFOA4 ppt–< 4
PFOS4 ppt–< 4
PFPeS4 ppt–< 4
PFTA8 ppt< 8< 8
PFTrDA7 ppt< 7< 7
PFUnA2 ppt–< 2
lithium9 µg/L< 9< 9

Statistics by compound

CompoundResultsDetectedHighest (date)Mean boundsKM medianP75P90P95
PFBA3136%67
2023-10-16
8.92–12.15<MRL7.62656
PFPeA3126%37
2023-10-16
3.7–5.93<MRL3.95.731
PFHxA3119%18
2023-10-16
1.62–4.04<MRL<MRL4.514
PFHpA316%4.6
2023-10-16
0.27–3.08<MRL<MRL<MRL3.8
6:2 FTS313%9.9
2023-04-28
0.32–5.16<MRL<MRL<MRL<MRL

Never detected (25): 11Cl-PF3OUdS, 4:2 FTS, 8:2 FTS, 9Cl-PF3ONS, ADONA, HFPO-DA, NEtFOSAA, NFDHA, NMeFOSAA, PFBS, PFDA, PFDoA, PFEESA, PFHpS, PFHxS, PFMBA, PFMPA, PFNA, PFOA, PFOS, PFPeS, PFTA, PFTrDA, PFUnA, lithium.

Left-censored Kaplan–Meier statistics (Helsel 2005; Helsel & Lee 2006, NADA for R). Units: ppt; lithium µg/L. Each compound has one reporting limit, so the Kaplan–Meier mean equals the upper mean bound (non-detects at the MRL); the lower bound sets non-detects to 0. “<MRL” = the percentile falls below the reporting limit and cannot be estimated. These describe this system's UCMR 5 samples, not population estimates.

Sources

  • EPA UCMR 5 occurrence data text files (UCMR5_All.txt; samples 2023-01-03 to 2026-06-17; data summary dated Jul 2026)
  • EPA SDWIS via ECHO SDWA downloads, quarter 2026Q3
  • EPA Public Water System Service Areas v3 (Mar 2026)
  • US Census Bureau cartographic boundary counties 1:500k, 2024
  • EPA/USGS NHDPlus V2 (medium resolution) flowlines, Strahler order 2+

Data build 171ad949e257 · 2026-10-18T04:10Z · UCMR 5 release Jul2026 · SDWIS 2026Q3. Data and methods.